OncoTalks | Oncology Insights at Your Fingertips
OncoTalks | Oncology Insights at Your Fingertips
Podcast Description
OncoTalks is the podcast for community oncology providers and clinicians who want to stay on top of new treatments and the latest advancements in oncology. Join Ontada Learn, and community oncologists from The US Oncology Network, as they explore oncology with a focus on the latest breakthroughs in cancer care. Expect concise, impactful discussions with practical clinical insights tailored for the real-world community oncology setting. Additionally, don’t miss OncoTalks Case Journeys, where experts deep dive into oncology patient cases and treatment journeys. Join as they conduct comprehensive case reviews, explore key learnings, and discuss the latest research and advances related to each case. Tune in to OncoTalks and start unlocking pathways to better patient care today!
Podcast Insights
Content Themes
The podcast covers a wide range of oncology topics including the latest treatments, advancements in cancer care, and comprehensive case reviews, with episodes highlighting specific treatments like antibody drug conjugates in HER2-low breast cancer and innovations in mCRC care through genomic insights.

OncoTalks is the podcast for community oncology providers and clinicians who want to stay on top of new treatments and the latest advancements in oncology. Join Ontada Learn and community oncologists from The US Oncology Network as they explore oncology with a focus on the latest breakthroughs in cancer care. Expect concise, impactful discussions with practical clinical insights tailored for the real-world community oncology setting.
Additionally, don’t miss OncoTalks Case Journeys, where experts deep dive into oncology patient cases and treatment journeys. Join as they conduct comprehensive case reviews, explore key learnings, and discuss the latest research and advances related to each case.
Tune into OncoTalks and start unlocking pathways to better patient care today!
In this episode, Drs. Loretta Nastoupil and Manali Kamdar sit down to discuss the evolving role of CAR T-cell therapy in relapsed or refractory LBCL, including patient eligibility, referral timing, and care coordination between referring and treatment centers.
Dr. Nastoupil is an oncologist with Southwest Oncology and CommonSpirit Mercy in Durango, Colorado. Dr. Kamdar is a Professor of Medicine and Clinical Director of the Lymphoma Program at the University of Colorado School of Medicine and the UCHealth Blood Disorders and Cell Therapies Center in Aurora, Colorado.
Dr. Nastoupil and Dr. Kamdar were compensated by Bristol Myers Squibb for their participation.
This episode was developed and produced by Bristol Myers Squibb and is distributed through OncoTalks with permission.

Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.